The Secretary of State for Science, Innovation and Universities visits the IISPV to learn about the progress of the Clinical Research Unit (UIC)
MORE INFO
The Secretary of State for Science, Innovation and Universities visits the IISPV to learn about the progress of the Clinical Research Unit (UIC)
The Clinical Research Unit (UIC) will allow clinical trials of medicines to be carried out on patients, from the most experimental phase to the final stage when their use is authorized
During the visit of the Secretary of State (D). Photo: IISPV
The Secretary of State for Science, Innovation and Universities, Juan Cruz Cigudosa, visited the facilities of the Pere Virgili Health Research Institute (IISPV), located in the Sant Joan University Hospital in Reus. The purpose of the visit was to learn about the development of the new Clinical Research Unit (UIC), a facility that will make it possible to carry out clinical trials with medicines on local patients in all phases—from phase 1, the most experimental, to phase 4, the final stage after which the medicine is approved for use. The CRU will occupy 500 m² and will be located inside the Sant Joan University Hospital in Reus. Its construction is supported by €4,300,000 in funding from the Carlos III Health Institute, the leading biomedical research organization under the Ministry of Science, Innovation and Universities.
During the visit, the Secretary of State was accompanied by the Government’s Deputy Representative in Tarragona, Elisabet Romero; the Mayor of Reus, Sandra Guaita; the City Councillor for Economic Promotion and Knowledge, Josep Baiges; the President of the IISPV Governing Board and Director of Health Services in Tarragona, Marta Milà; and other members of the IISPV Governing Board.
Juan Cruz Cigudosa emphasized that this is an important project that will become a reference point for clinical research in southern Catalonia. He also highlighted the importance of giving hospitals across the region access to this kind of infrastructure. In addition, he pointed out that “this is one of the highest-rated projects in a national funding call worth €45 million. This new unit has received almost 10% of the total budget available in that call, which was open to projects from all over Spain.”
Presentation of details of the Clinical Research Unit at Sant Joan Hospital in Reus
The Mayor of Reus, Sandra Guaita, added that “the amount of funding provided by the State shows that this is a strong project that will have a direct impact on citizens, as it will allow more equal access to medicines—something that used to happen only in large cities.”
In the same vein, the Director of IISPV, Joan Vendrell, explained that “this Clinical Research Unit will serve the entire province and benefit 850,000 people, from university hospitals to regional hospitals in different health areas.” He also said: “We would even like pharmacies to help share information about the studies being carried out, so that people can learn about them and, if they wish, take part.”
Since the funding was announced in early 2025, the tendering process for the construction work has already started, and part of the necessary equipment has been ordered. In terms of staff, six people have already joined IISPV to work directly with the CRU: two data managers, one administrative staff member, one radiology technician, and two nurses. The unit is expected to be operational by the end of 2026.
In 2025, the Institut d’Investigació Sanitària Pere Virgili (IISPV) celebrates 20 years of promoting research in health and biomedicine across the region. With more than 600 professionals and 38 research groups, the institute has become a key reference in transferring scientific knowledge to clinical practice. Years after its foundation, it continues working to improve the health and well-being of the population.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Facebook 
Mail 
WhatsApp 
